Jump to ContentJump to Main Navigation
An Insider’s Guide to Clinical Trials$
Users without a subscription are not able to see the full content.

Curtis L Meinert

Print publication date: 2011

Print ISBN-13: 9780199742967

Published to Oxford Scholarship Online: September 2011

DOI: 10.1093/acprof:oso/9780199742967.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 20 October 2021

Critics and Criticisms

Critics and Criticisms

(p.119) 14 Critics and Criticisms
An Insider’s Guide to Clinical Trials

Curtis L. Meinert

Oxford University Press

Consumers of information from trials must be able to size up the critics and criticisms of trials. There is no perfect trial. Hence, every trial is subject to criticism, so the issue is not whether or not there are criticisms, but rather what to make of them. The fundamental question always is whether the criticisms are sufficient to cause the reader to doubt or dismiss the results. This chapter begins with a brief description of the three general types of critics: clever critics, pontifical critics, and “Joe Friday” critics. It then presents a list of criticisms that researchers can ignore, being “universal criticisms,” that apply to any trial and, hence, should be viewed with a jaundiced eye unless supported by the facts.

Keywords:   clinical trial, research papers, criticisms, universal criticisms

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .